myopia san diego
Article
What Lasik Surgery Is For?
By John
LASIK surgery allows the complete cure of some regular eye conditions which many of us face.
Many of us suffer from the problem of being unable to read things at a distance. Medically such a condition would be termed as myopia. The only option till recently was to wear glasses. The worse your eyes were, the thicker your glasses got. But those days are over now. You now have the option to rectify the condition and see things normally without the aid of glasses and contact lens.
There are many who suffer from the problem of farsightedness of hyperopia. The problem is most visible in people who are around forty. Due to this condition a person would not be able to see what is close to his eyes. So reading from a book or a computer screen becomes very difficult if not impossible without the aid of reading glasses. At the same time since this condition generally happens pretty late in life it becomes kind of difficult for many to shift to reading glasses. In such cases LASIK proves to be the best available option.
LASIK surgery is a great way to deal with the problem of astigmatism. Now what is astigmatism. Astigmatism is where the patient has irregularities in his cornea which as a result distorts the image formed on the retina of the eye. LASIK can actually rectify this problem and help the patient to live a normal life.
Generally these are the three conditions that are cured through LASIK eye surgery.
However not all who suffer from these conditions would be eligible for the operation. Each patient has to meet a set of criteria.
First of all you have to be over 18 years in age. Many doctors would even want their patients to be at least 21. They wait to be sure that your eyes don't get rid of the complications with time.
If you are into serious physical activity and it is part of your career, then also LASIK is not an option for you.
Even pregnancy would stop you from having the LASIK operation done. There are hormonal imbalances during pregnancy and this might lead to skewed results after the operation.
Your eligibility will be nullified if you are suffering from any of the conditions like diabetes, glaucoma, rheumatoid arthritis, herpes infection of the eye or lupus. Make sure you do the necessary examinations before committing yourself to the surgery.
Article Source: http://www.article-outlet.com/
![]() |
What causes myopia? Could My Parents Have Prevented It?
By Dr Andrew Fink It was once John Lennon. Now Harry Potter has become the latest folk hero to be recognized by his trademark glasses. But being myopic (near or short-sighted) is not necessarily desirable judging Read more... |
![]() |
How Much Of A Breakthrough Is Intralase In Lasik Eye Surgery By John Opting for the right LASIK surgery to correct your vision today is not the same as it was a decade ago. This is comparatively a recent medical breakthrough. It was only in 1994 that the first eye Read more... |
Related RSS Feeds
Article Title: Promedior Announces Initiation Of Phase 2a Of Anti-Fibrotic Therapeutic, PRM-151, In The Prevention Of Post-Surgical Scarring In Glaucoma Patients Release Date: Thu, 09 Sep 2010 01:00:00 PDT Description: Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced that it has initiated a Phase 2a clinical study of PRM-151 to evaluate the efficacy, safety, and tolerability of PRM-151 in preventing post-surgical scarring in glaucoma patients following glaucoma filtration surgery... |
Article Title: Can-Fite BioPharma Announces The Initiation Of Phase 3 In Dry Eye Syndrome Release Date: Wed, 08 Sep 2010 07:00:00 PDT Description: Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome... |
Article Title: ThromboGenics Presents Positive Pooled Results From The MIVI-TRUST Phase III Program Release Date: Tue, 07 Sep 2010 00:00:00 PDT Description: ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France... |
Article Title: American Academy Of Ophthalmology Joins Forces With Middle East Africa Council Of Ophthalmology For Joint Meeting In Chicago October 16 To 19 Release Date: Mon, 06 Sep 2010 02:00:00 PDT Description: The largest and most comprehensive ophthalmic educational meeting in the world, the American Academy of Ophthalmology's (Academy) 2010 Joint Meeting in conjunction with the Middle East Africa Council of Ophthalmology (MEACO) will be taking place in Chicago, October 16 to 19... |


